Provided by Tiger Trade Technology Pte. Ltd.

Royalty Pharma plc

62.56
+1.151.87%
Volume:41.84K
Turnover:2.60M
Market Cap:36.09B
PE:33.56
High:62.56
Open:61.82
Low:61.82
Close:61.41
52wk High:62.56
52wk Low:34.08
Shares:576.94M
Float Shares:392.53M
Volume Ratio:1.88
T/O Rate:0.01%
Dividend:0.91
Dividend Rate:1.46%
EPS(TTM):1.86
EPS(LYR):1.78
ROE:13.97%
ROA:5.09%
PB:5.28
PE(LYR):35.12

Loading ...

Royalty Pharma Reports Second Quarter 2026 Results

THOMSON REUTERS
·
Aug 05

Royalty Pharma: Outlook 2026 Portfolio Receipts $3,400 Mln to $3,500 Mln, Interest Paid $350 Mln to $360 Mln

THOMSON REUTERS
·
Aug 05

Royalty Pharma Names Greg Raskin SVP, Head of Academic Initiatives

Reuters
·
Aug 03

Royalty Pharma Appoints Greg Raskin as Senior Vice President, Head of Academic Initiatives

THOMSON REUTERS
·
Aug 03

Earning Preview: Royalty Pharma plc revenue is expected to increase by 1.34%, and institutional views are bullish

Earnings Agent
·
Jul 29

Royalty Pharma Acquires Royalty Interest in AstraZeneca's Cliramitug

MT Newswires Live
·
Jul 22

Royalty Pharma Buys Cliramitug Royalty Stake from Neurimmune for up to $425 Million

Reuters
·
Jul 22

Neurimmune: in Q1 of 2027, Royalty Pharma Will Provide Another $125 Mln in Cash to Co

THOMSON REUTERS
·
Jul 22

Neurimmune Sells a Portion of Its Royalty Interest in Cliramitug to Royalty Pharma

THOMSON REUTERS
·
Jul 22

Neurimmune: Sold Portion of Its Royalty Interest in Cliramitug to Royalty Pharma for up to $425 Mln

THOMSON REUTERS
·
Jul 22

Royalty Pharma Maintains Quarterly Dividend at $0.235 a Share, Payable on Sept. 10 to Shareholders of Record on Aug. 14

MT Newswires Live
·
Jul 18

Press Release: Royalty Pharma Declares Third Quarter 2026 Dividend

Dow Jones
·
Jul 18

Analysts Are Bullish on These Healthcare Stocks: Royalty Pharma (RPRX), Johnson & Johnson (JNJ)

TIPRANKS
·
Jul 16

Royalty Pharma to Report Q2 2026 Results, Host Conference Call

Reuters
·
Jul 16

Royalty Pharma to Announce Second Quarter 2026 Financial Results on August 5, 2026

THOMSON REUTERS
·
Jul 16

Royalty Pharma : TD Cowen Raises Target Price to $65 from $50

THOMSON REUTERS
·
Jul 13

Analysts Are Bullish on Top Healthcare Stocks: Scienture Holdings (SCNX), Royalty Pharma (RPRX)

TIPRANKS
·
Jul 10

Royalty Pharma EVP Christopher Hite Sells USD 7.38 Million in Common Shares

Reuters
·
Jul 03

Royalty Pharma Forecasts Q2 Portfolio Receipts at $740 Million-$760 Million

Reuters
·
Jul 01

Royalty Pharma EVP, Chairman Partnering Christopher Hite Sells USD 8.15 Million in Common Shares

Reuters
·
Jun 26